rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    BFRI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Biofrontera: 3 Key Takeaways for Long-Term Investors
      Nov 17Yahoo FinanceBFRI
      Biofrontera Inc. Q3 2026 Earnings Call Summary
      Nov 13Yahoo FinanceBFRI
      Earnings call transcript: Biofrontera Q3 2026 revenue rises 30% but EPS misses
      Nov 13Investing.comBFRI
      Biofrontera earnings missed by $0.28, revenue topped estimates
      Nov 13Investing.comBFRI
      Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth
      Nov 13Yahoo FinanceBFRI
      Biofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026
      Nov 6Yahoo FinanceBFRI
      Biofrontera submits application to expand Ameluz use for AKs
      Oct 8Investing.comBFRI
      Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full Body
      Oct 8Yahoo FinanceBFRI
      Transcript: Biofrontera Q2 2026 Earnings Conference Call - Biofrontera (NASDAQ:BFRI)

      On Thursday, Biofrontera (NASDAQ:BFRI) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial

      Sep 28BenzingaBFRI
      Biofrontera stock gets FDA approval for skin cancer treatment
      Sep 15Investing.comBFRI
      Biofrontera wins FDA approval for Ameluz to treat skin cancer
      Sep 14Investing.comBFRI

      This is the newest page. Registered accounts read further back.